Insider Buying: CombiMatrix Insider Purchases 7,500 Shares of Stock (CBMX)
CombiMatrix (NASDAQ:CBMX) Insider Robert Weslie Tyson bought 7,500 shares of the company’s stock on the open market in a transaction that occurred on Wednesday, August 27th. The stock was purchased at an average price of $2.04 per share, for a total transaction of $15,300.00. Following the completion of the acquisition, the insider now directly owns 7,500 shares in the company, valued at approximately $15,300. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Separately, analysts at Zacks reiterated an “outperform” rating on shares of CombiMatrix in a research note on Friday, August 8th. They now have a $3.50 price target on the stock.
CombiMatrix (NASDAQ:CBMX) opened at 1.87 on Tuesday. CombiMatrix has a 1-year low of $1.81 and a 1-year high of $4.44. The stock’s 50-day moving average is $2.13 and its 200-day moving average is $2.48. The company’s market cap is $20.7 million.
CombiMatrix Corporation is a molecular diagnostics company. The Company operates in the field of genetic analysis and molecular diagnostics through its wholly owned subsidiary, CombiMatrix Molecular Diagnostics, Inc located in Irvine, California.
Receive News & Ratings for CombiMatrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CombiMatrix and related companies with Analyst Ratings Network's FREE daily email newsletter.